 Acquires undervalued biomedical assets to accelerate their development Developing drugs and therapies to treat pediatric nonverbal autism, liver cancer, and glaucoma Produces cancer bone-pain drug Strontium89 for sale in all 50 US states What Q BioMed does: Q BioMed Inc OTCMKTS:QBIO is a biotech company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. The New York City-based company has a pipeline of drugs and therapies to treat metastatic cancer bone pain, pediatric non-verbal autism, liver cancer, and glaucoma. 